FR EN
MI COMMUNITY
Today Marseille Immunopôle is a great opportunity to challenge our discipline with novel perspectives.

Daniel OLIVE
AMU, IPC, CRCM

MI COMMUNITY
“Our immunotherapy antibodies are positioned at the crossroads of two immunology fields with high potential: the g9d2 T cells and a novel superfamily of immunomodulators, butyrophilins”

Pierre d’EPENOUX
Imcheck Therapeutics

MI COMMUNITY
Understanding its mechanisms of action and proposing new diagnostic and therapeutic solutions is the ambitious project that we set with my team.

Marcel BLOT-CHABAUD
VRCM

MI COMMUNITY
Marseille Immunopôle (Marseille Immunology Center) has the potential to provide precious help to open new diagnostic and therapeutic pathways and to provide our patients with even more options. 

Pascale TOMASINI
AP-HM, AMU

MI COMMUNITY
Cell- and tissue- based therapies and gene therapies hold great promise in the field of both immunotherapy and regenerative medicine.

Christian CHABANNON
AMU, IPC, AP-HM, Inserm

MI COMMUNITY
Today, the Covid-19 pandemic serves as an eye-opener, once again demonstrating the strength of the Marseille Immunopôle collective

Nassima CHOUAKI BENMANSOUR
AP-HM

Newsletter
Stay informed
Subscribe
MI COMMUNITY
MI carries a strong voice for immunology research, freeing partners from their public or private sectors, breaking down disciplinary barriers and creating the essential conditions for acting together, quickly and sustainably

Emilie GARRIDO-PRADALIE
AP-HM

MI COMMUNITY
MI-mAbs allows researchers to validate the therapeutic potential of their discovery and permits industrials to focus their efforts on the most promising drug candidate

Francois ROMAGNÉ
AMU, MI-mAbs

MI COMMUNITY
Veracyte (formerly HaliodDx) is a key player in the MI ecosystem that allows both personalized immunotherapies utilization and acceleration of their development.

Vincent FERT
Veracyte

MI COMMUNITY
For many years our service at the Timone Hospital has collaborated with researchers including the " Natural Killer Cells and Innate Immunity" team of Eric VIVIER .

Nicolas SCHLEINITZ
AP-HM, AMU

Update of The Pioneer Project : 422 patients in the biomarker program, 65 patients in the umbrella clinical trial Read more
MI COMMUNITY
Marseille Immunopole should allow us now to accelerate the development of therapeutic antibodies, the new drugs that are changing the course of cancer treatment.

Jean-Paul BORG
AMU, IPC, CRCM

MI COMMUNITY
MI both accelerates research and development in immuno-oncology and offers cancer patients more options in terms of diagnostics and treatments, as well as more innovative clinical trials.

Fabrice BARLESI
AMU, Gustave Roussy, The Pioneer Project

MI COMMUNITY
Diagnostic in immuno-oncology is an innovative field combining the latest discoveries in immunology and new imaging technologies, such as digital pathology.

Fabienne HERMITTE
Veracyte

MI COMMUNITY
The Pioneer Project is unique as a strong public/private partnership between academia, a medical cancer center, 3 biotechs and a major pharma

Bernard A. FOX
Providence Cancer Institute, Portland, Oregon | UbiVac